Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Speculating in Takeover Targets -- Ignore unavailable to you. Want to Upgrade?

To: richardred who wrote (2671)	1/7/2011 11:09:22 AM
From: Grantcw	Respond to of 7243

Yeah, good point, there's definitely some risk here, as with any investment. Overall, I'm still comfortable as long as there are good call premiums to write against. The stock has rebounded today (which to me is less important), but there were positives and negatives in the PR including the fact that they already have enough inventory for the next 12 months and that some private insurers are accepting their drug. We'll see how it all works out... Thanks, Grant

To: richardred who wrote (2671)	1/19/2011 1:05:49 PM
From: richardred	Read Replies (1) \| Respond to of 7243

FWIW-at face value Savient "Open" to Takeover Approaches (SVNT) By Benzinga Staff January 19, 2011 12:35 PM Symbols: SVNT Posted in: News, Rumors Share 0diggsdigg Savient Pharma (NASDAQ: SVNT) is "open" to takeover approaches, according to recent chatter. The shares recently spiked to $11.27 on M&A rumors. This article may include mentions of rumors, chatter, or unconfirmed information. Readers should beware that while unconfirmed information may be correlated with increased volatility in securities, price movements based on unofficial information may change quickly based on increased speculation, clarification, or release of official news. Neither Benzinga nor its staff recommend that you buy, sell, or hold any security. We do not offer investment advice, personalized or otherwise. Benzinga recommends that you conduct your own due diligence and consult a certified financial professional for personalized advice about your financial situation. Read more: benzinga.com